BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22005072)

  • 1. In vitro activity of pentamidine against Tropheryma whipplei.
    Rolain JM; Fenollar F; Raoult D
    Int J Antimicrob Agents; 2011 Dec; 38(6):545-7. PubMed ID: 22005072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium.
    Boulos A; Rolain JM; Mallet MN; Raoult D
    J Antimicrob Chemother; 2005 Feb; 55(2):178-81. PubMed ID: 15650004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of classic Whipple's disease: from in vitro results to clinical outcome.
    Lagier JC; Fenollar F; Lepidi H; Giorgi R; Million M; Raoult D
    J Antimicrob Chemother; 2014 Jan; 69(1):219-27. PubMed ID: 23946319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.
    Lagier JC; Fenollar F; Lepidi H; Raoult D
    J Antimicrob Chemother; 2011 May; 66(5):1188-9. PubMed ID: 21393129
    [No Abstract]   [Full Text] [Related]  

  • 5. Tropheryma whipplei and Whipple's disease.
    Fenollar F; Lagier JC; Raoult D
    J Infect; 2014 Aug; 69(2):103-12. PubMed ID: 24877762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates.
    Fenollar F; Trani M; Davoust B; Salle B; Birg ML; Rolain JM; Raoult D
    J Infect Dis; 2008 Mar; 197(6):880-7. PubMed ID: 18419351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropheryma whipplei aortic valve endocarditis without systemic Whipple's disease.
    Chan V; Wang B; Veinot JP; Suh KN; Rose G; Desjardins M; Mesana TG
    Int J Infect Dis; 2011 Nov; 15(11):e804-6. PubMed ID: 21880531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whipple's disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat them.
    Lagier JC; Raoult D
    Curr Opin Infect Dis; 2018 Dec; 31(6):463-470. PubMed ID: 30299363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.
    Lagier JC; Fenollar F; Lepidi H; Raoult D
    J Antimicrob Chemother; 2010 Sep; 65(9):2005-12. PubMed ID: 20639526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocarditis due to Tropheryma whipplei: rapid detection, limited genetic diversity, and long-term clinical outcome in a local experience.
    Escher R; Roth S; Droz S; Egli K; Altwegg M; Täuber MG
    Clin Microbiol Infect; 2010 Aug; 16(8):1213-22. PubMed ID: 19732090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute infections caused by Tropheryma whipplei.
    Lagier JC; Fenollar F; Raoult D
    Future Microbiol; 2017 Mar; 12():247-254. PubMed ID: 28262041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells.
    Boulos A; Rolain JM; Raoult D
    Antimicrob Agents Chemother; 2004 Mar; 48(3):747-52. PubMed ID: 14982759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro.
    Fenollar F; Perreal C; Raoult D
    Int J Antimicrob Agents; 2014 Apr; 43(4):388-90. PubMed ID: 24613421
    [No Abstract]   [Full Text] [Related]  

  • 14. Tropheryma whipplei Infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease.
    Dreier J; Szabados F; von Herbay A; Kröger T; Kleesiek K
    J Clin Microbiol; 2004 Oct; 42(10):4487-93. PubMed ID: 15472298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.
    Bakkali N; Fenollar F; Biswas S; Rolain JM; Raoult D
    J Infect Dis; 2008 Jul; 198(1):101-8. PubMed ID: 18500934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropheryma whipplei in the skin of patients with classic Whipple's disease.
    Angelakis E; Fenollar F; Lepidi H; Birg ML; Raoult D
    J Infect; 2010 Sep; 61(3):266-9. PubMed ID: 20600302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on: evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.
    Carlson JA; Schaller J; Sell S
    J Antimicrob Chemother; 2011 Nov; 66(11):2681-2. PubMed ID: 21856790
    [No Abstract]   [Full Text] [Related]  

  • 18. [From Whipple's disease to Tropheryma whipplei infections].
    Lagier JC; Fenollar F; Raoult D
    Med Mal Infect; 2010 Jul; 40(7):371-82. PubMed ID: 20079990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Tropheryma whipplei infective endocarditis of the aortic and mitral valves in association with psoriatic arthritis and lumbar discitis.
    Whistance RN; Elfarouki GW; Vohra HA; Livesey SA
    J Heart Valve Dis; 2011 May; 20(3):353-6. PubMed ID: 21714430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple's disease.
    Bonhomme CJ; Renesto P; Desnues B; Ghigo E; Lepidi H; Fourquet P; Fenollar F; Henrissat B; Mege JL; Raoult D
    J Infect Dis; 2009 Apr; 199(7):1043-52. PubMed ID: 19222368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.